Personalized Medicine and Hereditary Cancer

Current comprehensive treatment of the cancer patient depends fundamentally on a personalized diagnosis based on molecular and genetic diagnostics, so our center uses:

  • Conventional molecular diagnostics techniques: identification by means of specific mutations: KRAS, EGFR, BRAF.
  • Genetic sequencing service with latest generation high performance technologies (NGS) for personalized cancer diagnosis, targeted therapies and multiple genetic testing for therapy selection.
  • Access to commercial personalized cancer diagnostics platforms (Oncotype, Mammaprint, Foundation Medicine).
  • The laboratory is also responsible for genetic testing that is vital in studying susceptibility to hereditary cancer.